2024 is off to a groundbreaking start as Baylor College of Medicine officially launches its clinical investigation into psilocybin-assisted therapy for veterans with PTSD. This historic study marks a major milestone in expanding access to innovative treatments for veterans—and it wouldn’t have been possible without the dedicated advocacy efforts of VETS and our partners.

This research initiative stems directly from the passage of Texas House Bill 1802 (HB1802) , a legislative victory spearheaded by VETS that gained overwhelming bipartisan support in the Texas House and Senate. The bill authorized the first state-funded studies into psychedelic-assisted therapy for veterans, setting the stage for Baylor’s landmark investigation.

Now, Dr. Lynnette Averill and her team at Baylor College of Medicine are enrolling veterans to participate in this pioneering study.

What the Study Involves

This clinical trial will examine the effects of two doses of psilocybin—administered in a safe, supportive environment—on veterans living with PTSD. The treatment protocol includes:

  • Preparation Sessions – Helping participants set intentions and build trust with their therapy team.
  • Dosing Sessions – Two supervised psilocybin sessions designed to facilitate breakthroughs in trauma processing.
  • Integration Sessions – Post-experience support to help veterans apply insights from their sessions into everyday life.

This research represents a critical step toward proving the efficacy and safety of psilocybin-assisted therapy for veterans, and we’re excited to see how this study contributes to the future of trauma healing.

Interested in Participating?

If you or a loved one is a veteran interested in this study, you can complete the pre-screener to determine eligibility.

About the Author

Dylan Orion, Director of Research Dylan Orion has worked on several clinical trials investigating the therapeutic efficacy of psilocybin for a range of conditions. He studied at the Johns Hopkins Center for Psychedelic and Consciousness Research where he received a degree in psychedelic informed Neuroscience. Additionally, Dylan is trained in psychedelic facilitation and integration through the Usona Institute and Johns Hopkins Medicine.